mots c vs ipamorelin MOTS-c reduces myostatin and muscle atrophy signaling | American Journal of Physiology-Endocrinology and Metabolism MOTS-c - 10mg - Orion

By day 3-4 of multi-dose use, microbial contamination becomes likely

Injection burden 2-3 injections per day on TB-500 days Best for Dose flexibility, injury-focused work Cycle driver GHK-Cu cycling typically sets the cycle length BPC-157 Loading 250-500 mcg/day (weeks 1-4) Frequency Daily Maintenance 250 mcg/day (weeks 5-8+) Route SubQ near injury or oral TB-500 Loading 2.5-5 mg per injection (weeks 1-4) Frequency 2x/week Maintenance 2 mg per injection (weeks 5-8+) Route SubQ systemic GHK-Cu Loading 1-2 mg/day (weeks 1-4) Frequency Daily Maintenance 1 mg/day (weeks 5-8+) Route SubQ Weekly Schedule Example Monday BPC-157 500 mcg + TB-500 2.5 mg + GHK-Cu 1-2 mg Tuesday BPC-157 500 mcg + GHK-Cu 1-2 mg Wednesday BPC-157 500 mcg + GHK-Cu 1-2 mg Thursday BPC-157 500 mcg + TB-500 2.5 mg + GHK-Cu 1-2 mg Friday BPC-157 500 mcg + GHK-Cu 1-2 mg Saturday BPC-157 500 mcg + GHK-Cu 1-2 mg Sunday BPC-157 500 mcg + GHK-Cu 1-2 mg Use a separate syringe for each compound

Hexosamine pathway Excess glucose not metabolized via glycolysis can enter the hexosamine pathway, which leads to increased production of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), which is used for O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins

A.DashwoodR

This is because if you are not taking the right form of glutathione then your body will break it down before you can ever get the benefit

Expecting faster results leads to premature discontinuation before benefits manifest, the most common reason GHK-Cu "fails" to work